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Objective: The efficacy of video-assisted thoracic surgery for thymectomy 
with myasthenia gravis has not been examined. Methods: Thirty-three 
consecutive patients underwent total thymectomy by video-assisted tech- 
niques between 1992 and 1995. There were 13 male and 20 female patients 
with a mean age of 38.42 -- 16.88 years (range 9 to 84 years). The 
procedures were performed by either a right (n = 11) or left (n = 22) 
thoracoscopic approach and all anterior mediastinal tissue was removed. 
Results: There was no perioperative mortality or long-term morbidity. One 
patient required conversion of the video.assisted thechnque to a lateral 
thoracotomy. All patients except one were extubated immediately. The 
mean hospital stay was 4.12 -- 6.07 days (range 1 to 37 days) with a median 
of 3 days. Mean follow-up is 23.39 - 11.72 months (range 4 to 47 months). 
Clinical improvement was seen in 87.9% (29/33): one of two patients (50%) 
in stage I, 17 of 19 (89.4%) in stage IIA, eight of nine (88.8%) in stage IIB, 
and three of three (100%) in stage III. Metaanalysis of these results 
compared with results in nine published series in which other techniques 
were used showed no difference in clinical improvement after thymectomy 
between series. Conclusion: We conclude that video-assisted thymectomy is 
as effective as the traditional open surgical approaches for performance of 
thymectomy in the management of patients with myasthenia gravis. In 
addition, the improved cosmesis of the video-assisted approach ideally will 
lead to earlier thymectomy in patients with myasthenia gravis. (J Thorac 
Cardiovasc Surg 1996;112:1352-60) 
M yasthenia gravis is a chronic autoimmune dis- 
order in which surgical thymectomy has been 
demonstrated to have a positive effect on the course 
of the disease in most patients. Complete removal of 
all thymic tissue is believed to be necessary to 
maximize the surgical results) Standard surgical 
approaches include the transsternal, transcervical, 
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and the "maximal" thymectomy, which combines 
the transsternal nd transcervical pproaches. 24All 
of these procedures have demonstrated efficacy. 
The role of video-assisted thoracic surgery 
(VATS) has been well defined for the management 
of a number of diseases. 5 For many medical prob- 
lems such as the treatment of malignant pleural 
effusions, lung biopsy, and spontaneous pneumotho- 
rax, the benefits of the procedure are immediate and 
obvious and are adequately evaluated by short-term 
follow up. 6-8 However, for other diseases in which 
the course is variable and the results of an interven- 
tion are not immediately apparent, such as myasthe- 
nia gravis, a longer period of follow-up is necessary 
before the procedure can be assessed. 9 Although the 
ability to technically perform a thymectomy by the 
less invasive VATS technique was immediately ap- 
parent, the efficacy of the procedure in comparison 
with accepted standards required long-term follow- 
up. 1° The purpose of this study is to evaluate the 
efficacy of the VATS approach for thymectomy by 
intermediate-term results and to compare those 
results with published standard results. 
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Fig. 2. The arterial blood supply to the thymic gland 
arising from the internal thoracic artery is ligated with 
clips and divided. 
Fig. 1. Thymic dissection by the VATS approach is 
started at the inferior pole of the gland anterior to the 
phrenic nerve. SVC, Superior vena cava. 
Patients and methods 
Thirty-three patients underwent VATS thymectomy at
four participating institutions between March 1992 and 
October 1995. These institutions were Columbia Hospital 
at Medical City Dallas, Dallas, Texas (13 patients), Prince 
of Wales Hospital, Hong Kong (10 patients), University of 
Pittsburgh, Pittsburgh, Pennsylvania (6 patients), and St. 
Luke's Hospital, Milwaukee, Wisconsin (4 patients). The 
thoracic surgeons at each institution had already gained 
significant VATS experience with technically more simple 
procedures before embarking on this study. All patients 
gave informed consent after being apprised of the vari- 
ables, which included the unproven ature of the VATS 
approach and the possibility of conversion to an open 
approach if safety or the ability to perform a complete 
thymectomy was in doubt. They were also offered the 
option of the more standard approaches. 
In all patients myasthenia gravis was confirmed by 
clinical features as well as by one or more of the following: 
electromyographic studies, edrophonium chloride (Tensi- 
lon) test, and circulating acetylcholine receptor antibody 
studies. A computed tomogram was obtained on all 
patients. No specific preoperative preparation or ptimi- 
zation regimen including plasmapheresis was performed. 
All patients with myasthenia gravis were included in this 
series, including those patients who had thymomas. 
Surgical technique. The VATS procedure isperformed 
with the patient under general endotracheal nesthesia 
with a double-lumen tube to effect ipsilateral ung col- 
lapse. A left-sided tube is used in all patients. The patient 
is placed at a 30-degree angle from horizontal by a roll 
placed under the back on the side through which the 
thymus is being approached. Three 10 mm incisions are 
made in either the right or left infraaxillary area depend- 
ing on which side of the chest is to be entered. A 
30-degree angled telescope is placed through the middle 
incision and the grasping instrument and scissors through 
the lateral ones. With the use of standard endoscopic 
instruments including a tissue-grasping forceps and endo- 
scopic scissors, the dissection is begun at the inferior 
portion of the thymic gland just anterior to the phrenic 
nerve (Fig. 1). By a combination of sharp and blunt 
dissection, all anterior mediastinal tissue is teased off the 
pericardium. The mediastinal pleura is then divided in the 
retrosternal area and the ant rior portion of the thymic 
gland is dissected from the retrosternal rea. The arterial 
blood supply to the thymic gland that arises from the 
internal thoracic artery is next ligated with endoscopic 
clips (Fig. 2). At this point the innominate vein can be 
identified. Dissection is carried carefully along the innom- 
inate vein until the thymic branches entering the innom- 
inate vein are identified and also divided with an endo- 
scopic clip (Fig. 3). Next, the gland is dissected off the 
contralateral pleura. This is done by blunt dissection so 
that the contralateral phrenic erve is not injured. Once 
the gland is mobilized to this point, it is often helpful to 
introduce afan retractor or other instrument to retract the 
bulk of thymic tissue out of the way so that dissection into 
the cervical area can continue. Finally, dissection is car- 
ried cephalad to the innominate vein until the superior 
horns of the thymic gland are identified. The fascial 
attachments of the thymic gland to the inferior portion of 
the thyroid gland are divided. The most difficult area to 
access and visualize is the recess between the superior 
vena cava-innominate v in junction. For this reason we 
have frequently found it easier to visualize this area 
through the right thoracoscopic approach. We have also 
found that the 30-degree telescope significantly aids visu- 
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Fig, 3. After identification of the innominate vein, the 
thymic branches are clipped and divided. 
alization, especially when the dissection is above the 
innominate vein into the cervical area. 
When the dissection of the thymic gland is complete 
including the cervical area, the tissue is removed through 
an anterior trocar site (Fig. 4). We routinely place the 
tissue in a specimen bag, which allows easier extraction of 
tissuewithout fragmentation. It also obviates the concern 
of potential seeding of the chest wall if a thymoma is 
present in the specimen. Hemostasis i obtained and the 
lung is reinflated. A chest tube or drain is not routinely 
used. The incisions are closed with a subcuticular suture. 
The patients are extubated in the operating room. After 
a period of observation in the recovery room, they are 
returned to a thoracic surgical floor. The preoperative 
medications including anticholinergic drugs and fre- 
quently steroids are restarted at their preoperative doses. 
After an initial period of stabilization after the operation, 
if the patient is receiving steroids, the medication is 
gradually tapered over a 4- to 6-month period. Anticho- 
linergic medication is then slowly tapered over the ensuing 
4 to 6 months. 
Statistical analysis. The association between surgical 
outcome and a series of preoperative patient and clinical 
variables in this series was assessed by means of X 2, 
Fisher's exact test, and Kendall's ~- as appropriate. All 
statistical procedures were performed with the use of SAS 
version 6.06 (SAS Institute, Inc., Cary, N.C.) on an 
IBM-compatib!e computer. Results were considered sig- 
nificant if the observed probability was less than 0.05. The 
Fig. 4. Typical thymus specimen after VATS dissection. 
Removal of all anterior mediastinal tissue in addition to 
the thymic gland is demonstrated. 
variables examined included duration of symptoms, sex, 
age, preoperative Osserman classification, and pathology. 
Contingency tables were evaluated by )(2 and Fisher's 
exact tests. 
Results 
The results of 33 consecutive thymectomies per- 
formed at four institutions by means of VATS 
between March 1992 and October 1995 are listed in 
Table I. The severity of preoperative disease was 
graded by means of the Osserman classification 11 
(Table II). Surgical outcome was scored following 
the criteria used by DeFilippi, Richman, and Fergu- 
son 12 (Table III). 
The study population consisted of 20 female and 
13 male patients. The mean age was 38 _+ 16.9 years 
(range 9 to 84 years) with a mean duration of 
symptoms of 16 _+ 12.9 months (range 2 to 48 
months) (Table IV). Twenty-two procedures were 
performed through the left side of the chest and 11 
through the right side. Intraoperative bleeding from 
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Table I. Results of VATS thymectomy formyasthenia gravis 
Duration of Postop. Preop. Postop. 
preop, symptoms hospital stay Follow-up classification classification Steroids 
Patient Age, sex (too) (days) Pathology (rno) (Osserman) (DeFilippi) preop./weaned 
1 27, F 48 2 Hyperplasia 47 2 1 No/ -  
2 58, F 2 3 Thymoma 46 2 2 No/-- 
3 23, F 15 3 Hyperplasia 42 2 3 No/ -  
4 59, M 48 2 Atrophic 37 2 4 Yes/no 
5 32, M 6 3 Hyperplasia 34 2 3 Yes/yes 
6 32, F 2 3 Thymoma 33 3 3 Yes/no 
7 48, F 12 1 Hyperplasia 29 2 2 No/ -  
8 32, F 5 1 Normal 26 2 1 Yes/yes 
9 37, M 6 1 Normal 22 2 2 No/-- 
10 45, M 6 5 Thymoma 14 2 3 No/ -  
11 39, M 8 5 Thymoma 25 2 2 Yes/yes 
12 9, M 17 3 Hyperplasia 23 2 2 Yes/yes 
13 29, F 22 37 Hyperplasia 22 3 2 Yes/yes 
14 52, M 14 3 Thymoma 21 2 2 Yes/yes 
15 34, F 15 5 Normal 19 2 2 No/-- 
16 76, M 12 5 Thymoma 15 2 3 No/-- 
17 31, F 10 4 Normal 18 2 2 No/-- 
18 29, F 16 5 Normal 17 3 2 Yes/yes 
19 75, M 9 2 Normal 14 2 3 No/-- 
20 17, M 20 2 Hyperplasia 13 1 4 Yes/no 
21 25, F 13 3 Hyperplasia 22 2 4 Yes/no 
22 39, F 7 5 Hyperplasia 9 2 3 Yes/yes 
23 38, F 9 5 Hyperplasia 24 2 2 Yes/yes 
24 84, M 6 3 Atrophic 7 2 2 No/-- 
25 33, F 5 5 Hyperplasia 28 2 3 Yes/no 
26 32, F 7 2 Hyperplasia 12 1 1 Yes/yes 
27 52, M 30 5 Hyperplasia 34 2 4 Yes/no 
28 42, M 36 3 Hyperplasia 37 2 1 No/-- 
29 30, F 18 2 Hyperplasia 35 2 1 No/-- 
30 33, F 9 2 Hyperplasia 31 2 1 Yes/yes 
31 24, F 48 1 Hyperplasia 6 2 2 No/-- 
32 22, F 24 1 Hyperplasia 6 2 3 Yes/no 
33 30, F 24 4 Hyperplasia 4 2 3 No/-- 
a thymic vein occurred in one patient early in our 
experience and required a limited lateral thoracot- 
omy to control. All other patients were extubated in 
the operating room except for one patient with 
Down's syndrome who subsequently had postoper- 
ative pneumonia and required prolonged ventila- 
tion. No other intraoperative or postoperative 
complications occurred. Specifically, there were no 
instances of phrenic or recurrent nerve injuries, 
wound infections, or hypocalcemia. In no instance 
did the surgeon believe that conversion to an open 
approach was necessary to remove all thymic tissue. 
There was no mortality. Care in the intensive care 
unit was not routinely required. The mean hospital 
stay was 4.12 ± 6.07 days (range 1 to 37 days), with 
a median stay of 3 days. 
Six patients had thymoma, all of which were 
diagnosed before the operation by computed tomo- 
graphic scan. There was no evidence of invasion by 
scan or during the operation, and all thymomas were 
classified as stage I by the Masaoka classificationJ 3
There has been no recurrence of tumor in the six 
patients with thymoma. 
Mean follow-up is 23.39 _+ 11.72 months (range 4 to 
47 months). Clinical improvement was seen in 87.9% 
(29/33) of patients: one of two (50%) in stage I, 17 of 
19 (89.4%) in stage IIA, eight of nine (88.8%) in stage 
IIB, and three of three (100%) in stage III. Complete 
remission, that is, no symptoms and no medications, 
occurred in six patients (18%). Four patients did not 
have a change in clinical status after thymectomy, and 
no patient had deterioration in clinical status. 
Because of the small number of patients, multi- 
variate analysis of factors was not feasible. Analysis 
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Table II. Osserman classification of myasthenia 
gravis 
Stage Description 
Stage I
Stage IIA 
Stage IIB 
Stage III 
Stage IV 
Occular myasthenia gravis: involvement of
extraocular muscles only 
Mild generalized myasthenia gravis: general- 
ized weakness without respiratory muscle 
involvement 
Moderately generalized myasthenia gravis: 
significant manifestation of weakness with 
exercise tolerance 
Acute fulminating myasthenia gravis: rapid 
onset (within 6 months) of respiratory 
muscle involvement 
Late severe myasthenia gravis: progressive in 
severity for 2 or more years 
Table III. DeFilippi postoperative classification 
Class Description 
Complete remission, no medications 
Asymptomatic, decreased medications 
Improved, decreased symptoms or decreased 
medications 
No change 
Worsening symptoms 
Table IV. Results of VATS thymectomy 
Mean duration of symptoms (mo) 
Mean length of stay (days) 
Mean follow-up (too) 
Patients treated with preoperative 
steroids 
Patients weaned off steroids 
16 -+ 12.9 
4.12 _+ 6.07 
23.39 -+ 11.72 
18 of 33 (54.5%) 
12 of 18 (66.7%) 
of the cross-tabulated data revealed no significant 
associations between the patient's ex and histologic 
features of the thymus and the preoperative grade 
or postoperative outcome (Tables V to VII). Fur- 
thermore, there was no correlation between the 
duration of the symptoms and the preoperative 
severity of the disease (~- = 0.017, p = 0.902) or 
between the length of follow-up and surgical out- 
come (~- = -0.159,p = 0.245). 
Comparisons with published outcomes. To as- 
sess the success of VATS thymectomy, we com- 
pared the surgical outcomes from the current 
series with outcomes reported elsewhere (Table 
VIII). Logistic analysis, using the SAS PROC 
CATMOD program, was performed to assess the 
relationship between treatment outcomes (com- 
plete remission or improvement) and surgical 
Table V. Outcome in relationship to preoperative 
stage 
No. of patients 
Preoperative Complete Moderately Mildly No 
clinical stage remission improved improved improvement 
I (n = 2) 1 0 0 1 
IIA (n = 19) 4 10 3 2 
IIB (n = 9) 1 1 6 1 
III (n = 3) 0 2 1 0 
Total (n = 33) 6 13 10 4 
Table VI. Sex of patients correlated with histologic 
tumor type 
Sex Atrophic Hyperplasia Thymoma Sex totals 
Male 4 5 4 13 
Female 4 14 2 20 
Histology totals 8 19 6 33 
Table VII. Outcome according to histologic type 
No. of Complete Total 
Histology patients remission improved 
Hyperplasia 19 5 16 
Atrophic 8 1 7 
Thymoma 6 0 6 
Total 33 6 29 
technique. Logistic analysis revealed a significant 
treatment effect for the proportion of patients 
having improved outcomes (X 2 = 21.54, p = 
0.0001) but not for the proportion of patients 
having complete remission (X 2 = 5.5,p = 0.1385). 
Inspections of the analysis of the weighted least 
squares estimates revealed that the proportion of 
patients having improved outcomes after thymec- 
tomy was significantly lower when the operation 
was performed by the sternotomy approach (X 2 = 
7.35, p = 0.0067) and significantly greater when 
performed by the combined sternotomy and tran- 
scervical approach (X 2 = 12.49, p = 0.0004). 
As a final step, our outcomes were compared with 
those reported by DeFilippi, Richman, and Fergu- 
son, 12 whose outcome criteria were used in the 
current series. Analysis of the cross-tabulated data 
demonstrated that the surgical outcomes of the 
current series are not significantly different from 
those reported by DeFilippi and associates (percent 
in complete remission: )(2 = 0.02,p = 0.887; percent 
improved: )(2 = 679, p = 0.41). 
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Table VIII. Comparison to published outcomes 
No. in 
Mean follow-up complete No. 
Series Technique (mo) remission improved 
Jaretzki et al., 1 1988 (n = 95) TS + TC 40 36 (37.9%) 88 (92.6%) 
Lennquist et al., 14 1990 (n = 30) TS + TC 50 6 (20%) 29 (96.7%) 
Total TS + TC (n = 125) 42 (33.6%) 117 (93.6%) 
Frist et al., 2 1994 (n = 46) TS 75 13 (28.2%) 40 (87%) 
Hatton et al., 1~ 1989 (n = 52) TS 46 14 (28%) 30 (57.7%) 
Nussbaum et al., 15 1992 (n = 48) TS 51 20 (41.7%) 45 (93.8%) 
Mulder et al., 17 1989 (n = 84) TS 36 30 (35.7%) 67 (79.8%) 
Kay et al., is 1994 (n = 36) TS 49 12 (24.5%) 26 (72.2%) 
Total TS (n = 266) 89 (33.5%) 208 (78.2%) 
Cooper et al., 3 1988 (n = 65) TC 41 (median) 34 (52.3%) 62 (95.4%) 
DeFilippi et al., 12 1994 (n - 53) TC 51 9 (17%) 43 (81.1%) 
Total TC (n = 118) 43 (36.4%) 105 (89%) 
Present study (n - 33) VATS (n = 33) 23 6 (18.2%) 29 (87.9%) 
TS, Transsternal; TC, transcervical; TS + TC, combined transsternal + transcervical. 
Discussion 
Myasthenia gravis is a chronic disease in which 
surgical thymectomy has been demonstrated to have 
a positive effect. Numerous techniques for perfor- 
mance of a thymectomy have been described and 
published, including the transsternal technique, the 
transcervical pproach, and the "maximal" thymec- 
tomy by the combined transcervical nd transtho- 
racic approach. In this article we describe our results 
of VATS for the performance of thymectomy. 
Minimal access does not mean minimal exposure. 
Despite the limited incisions necessary toperform a 
thymectomy by VATS, as with standard open ap- 
proaches, wide exposure to all of the anterior me- 
diastinum and cervical area is available. All anterior 
mediastinal tissue is totally removed because of the 
variability and location of thymic tissue. Moreover, 
the ability to completely dissect and remove the 
superior horns of the thymic gland into the cervical 
area is not compromised by this approach. 
Although the VATS approach can be performed 
on either side, we believe that the right side is 
technically easier for a number of reasons. First, 
there is increased room in the right thoracic avity 
allowing greater maneuverability of telescope and 
instrumentation. Second, the presence of the supe- 
rior vena cava as an early landmark allows easier 
definition of the vascular structures and identifica- 
tion of the innominate vein during the course of the 
dissection. Finally, the recess at the junction be- 
tween the superior vena cava and innominate vein is 
better visualized and defined from the right side. On 
the left side, this junction is the most difficult area in 
which to perform the dissection, whereas an ap- 
proach through the right side aids dissection i  this 
area. Although we consider thymectomy to be an 
advanced VATS procedure, it has not been as 
technically difficult as some other VATS procedures 
such as lobectomy and esophageal procedures. Time 
and patience on the part of thoracic surgeon are 
required for orderly execution Of the procedure. As 
we have gained experience, the average time of a 
VATS thymectomy has been reduced to approxi- 
mately lY2 hours. 
Complete thymectomy is believed to be necessary 
to achieve the maximal clinical benefit on the course 
of myasthenia gravis. However, the only way of 
gauging the effectiveness of the procedure is by 
clinical response. Because myasthenia gravis is a 
chronic disease of variable pattern, analyzing the 
benefit of the operation can be difficult. Published 
series contain heterogeneous groups of patients 
classified by different methods, and meaningful 
comparison can be difficult. Table VIII presents the 
results of nine published series of thymectomy for 
myasthenia gravis performed by various techniques. 
We have added the results of our series to this table 
for comparison. Accurate Comparison among all 
series is difficult because different preoperative clas- 
sifications are used in different series, including the 
Osterhuis, the Osserman, and the modified Osser- 
man classifications. In addition, different grading 
systems for response to thymectomy are used so 
that, again, totally accurate comparison between 
series is extremely difficult. Therefore we have com- 
pared the percentage of patients who were im- 
proved by thymectomy between different series, as 
well as the percentage of patients who obtained a
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Fig. 5. Remission rate for myasthenia gravis. 
complete remission, that is, free of symptoms and 
free of medications with thymectomy, by the differ- 
ent surgical techniques. Metaanalysis howed no 
difference in any single series in the percentage of 
patients with improvement. When clinical response 
was evaluated among combined series (Table VIII), 
the logistic analysis revealed that the proportion of 
patients having improved outcomes is significantly 
lower when thymectomy is performed by the ster- 
notomy approach (78.2%) and significantly greater 
when performed by the combined sternotomy and 
transcervical pproach (93.6%). However, in analy- 
sis of the combined approach series of Jaretzki and 
Wolff, 4 only 95 of 123 consecutive thymectomies 
were analyzed. This omission of 28 patients makes 
meaningful analysis and interpretation of their re- 
sults difficult. However, a lower complete response 
rate is shown in our series (18.2%), as well as in the 
transcervical technique series by DeFilippi, Rich- 
man, and Ferguson 12 (17%) compared with other 
series (20% to 52%). Although this could be indic- 
ative of a less effective procedure, we believe that 
more likely it is a reflection of the relatively short 
duration of follow-up in our patients. The mean 
follow-up in our series is 23 months. Five of our 
patients who were operated on less than 1 year ago 
have received asignificant benefit from thymectomy, 
but have not yet had a complete remission. In 
life-table analysis for attainment of complete remis- 
sion in Jaretzki's series of patients without thy- 
moma, the complete remission rate at 2 years was 
approximately 24%, very similar to our present 
series (18.6%) (Fig. 5). If we eliminate the patients 
with thymoma from our series, the complete re- 
mission rate improves to 22.2%, the same as in 
Jaretzki's series at the same length of follow-up. As 
we obtain longer follow-up times, we are optimistic 
that similar complete remission rates can be ob- 
tained by the VATS technique as by the other 
approaches. 
Numerous preoperative variables have been de- 
scribed in the different series as predicting response 
to thymectomy. Shorter duration of symptoms, fe- 
male sex, limited disease, more extensive disease, 
thymic hyperplasia, thymoma, and high titre acetyl- 
choline antibody receptor levels have been de- 
scribed as positive prognostic factors predictive of 
surgical results. Analysis of our own series showed 
no difference in clinical response to thymectomy in
any of the variables except for possibly classification 
IIA (see Table V). However, our series is too small 
to allow any meaningful conclusions. 
The question may be raised as to why a thymec- 
tomy should be done by this approach. Despite 
statements in the standard management of myas- 
thenia gravis that early thymectomy is best for 
results and is preferable to steroid therapy, this is 
not always clinical practice. As can be seen in our 
series, 18 of 33 patients (54.5%) were receiving 
steroids before the operation, and thymectomy 
was therefore presumably delayed in these pa- 
tients. Because a large proportion of patients with 
myasthenia gravis are young women, the undesir- 
able cosmetic effect of the surgical approach is 
often a deterrent, factor for early thymectomy and 
the option of steroids is chosen instead. It is 
hoped that the less invasive nature of the VATS 
procedure and the better cosmesis obtained will 
lead to earlier intervention in patients with myas- 
thenia gravis. 
In conclusion, the results of this series show that 
thymectomy by the VATS technique is as effective 
as other established surgical techniques in myasthe- 
nia gravis. The procedure is technically advanced. It
should be undertaken by thoracic surgeons who 
have gained experience in simpler VATS proce- 
dures and have developed an interest and enthusi- 
asm for the VATS approach. Because of the less 
invasive nature and superior cosmesis, it is hoped 
that patient and neurologist acceptance of thymec- 
tomy will increase and that referral for intervention 
will occur earlier in the course of the disease, when 
the response rate will be higher. 
We acknowledge the contributions of Kevin M. Kelly, 
PhD, for statistical nalysis of the results and Pat Albers 
and Melba Harris for manuscript preparation. 
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Discuss ion 
Dr. Paul A. Kirschner (New York, N.Y). I have two 
comments. The first relates to the anatomic efficacy of 
thoracoscopic thymectomy per se. In the almost century-old 
history of thymectomy, the problem has always been "how to 
do it and how much to take out." The thoracoscopic method 
appears to me to be most comparable to the limited mini- 
mally invasive transcervical method and subject o its same 
shortcomings. Proponents of more radical methods uch as 
thoracotomy, sternotomy (partial or complete), and various 
combined extended approaches all claim either "complete- 
ness" or "adequacy" of resection. These terms are not 
necessarily synonymous. Dr. Mack did not mention any 
search for or detection of ectopic thymic tissue in the 
mediastinal fat, accessibility to which is restricted by the 
limited exposure of thoracoscopy. Did it occur? 
Also, the thoracoscopic method continues to mature, 
including as it does variable positions on the operating 
table (supine vs oblique vs lateral), location of ports (right, 
left, or bilateral), with or without a supplementary cervical 
incision. Dr. Mack has switched from a left-sided to a 
right-sided approach. 
The second comment relates to the inclusion of the six 
thymomas in the clinical series of the 33 consecutive cases 
without detailed information such as histology or surgical 
stage. I presume that all were stage I completely encapsu- 
lated noninvasive thymomas. Could Dr. Mack kindly clarify 
that? He does not take into account either the unique nature 
of the myasthenia associated with thymomas as compared 
with that with nontumorous thymus (none of the six patients 
with thymomas had complete remission) or the unpredict- 
able long-range prognosis of thymoma per se, however 
"benign" it may be pathologically. 
Also, he makes no mention of the total patient pool 
from which these 33 cases were derived, nor does he 
indicate whether any patients were considered unsuitable 
for thoracoscopy for whatever eason, including those 
offered and refusing VATS. 
Our first patient o undergo transcervical thymectomy 
in 19671 had what we thought was an encapsulated 
thymoma. It recurred widely 8 years later, requiring 
extensive reoperation 2 via sternotomy. This illustrates the 
necessity for long-range follow-up to establish the efficacy 
of a limited operation for even a stage I thymoma. 
I would question the advisability of applying thoraco- 
scopic thymectomy to thymoma, just as I do for transcer- 
vical thymectomy. 
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Dr. Mack. Thank you, Dr. Kirschner. Regarding the first 
point, limited access does not necessarily mean limited 
exposure. We believe that the VATS approach allows ade- 
quate visualization of all anterior mediastinal tissue and 
accessibility for removal. We are well aware of the potential 
presence of ectopic thymic tissue, and therefore all anterior 
mediastinal tissue is removed. In this series we saw no 
evidence of ectopic thymic tissue in the mediastinal fat. 
Regarding the second issue of thymomas, all were 
encapsulated stage I thymomas in this series. All patients 
have been observed closely, and there is no evidence of 
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recurrence, but we are well aware that follow-up is very 
short. We also believe that we performed the same 
procedure by the VATS approach that we would have by 
the open approach. 
Dr. Joel D. Cooper (St. Louis, Mo.). I would argue that 
if you are going to do something less than a median 
sternotomy, the transcervical pproach may in fact have 
some benefit: it gives bilateral exposure, does not neces- 
sitate going through the pleural spaces, and provides 
excellent exposure of the neck region. In the last 80 
patients we have operated on over the past 5 years, half 
have gone home on the day after the operation, the mean 
and median hospital stay is less than 2 days, and the 
patients can return to work in several days. Furthermore, 
no chest ubes or drains are used. I would argue that this 
is as good a result as one is likely to achieve with any 
approach. 
If you want to use a thoracoscope, you can put it in 
through the cervical incision and get a beautiful bilateral 
view, if you should choose to add that. I would be 
concerned about access to the aortopulmonary window 
area from a right-sided approach, which is one of the most 
difficult areas from which to remove ctopic thymic tissue. 
I would also argue that the best test of a complete 
thymectomy is the complete remission rate. As you said, 
your results will have to be viewed as tentative until you 
can demonstrate a better complete remission rate than 
you have achieved to date. 
Finally, I would acknowledge that the disadvantage of 
the transcervical pproach is perhaps a more steep learn- 
ing curve. I might therefore suggest, somewhat tongue in 
cheek, that the VATS procedure might be one of the steps 
along that learning curve, after which you could graduate 
to a transcervical pproach. 
Dr. Mack. Thank you for your comments, Dr. Cooper. 
I find that the very similar arguments hat we used for the 
VATS approach for thymectomy, aswell as for all VATS 
procedures, were exactly those that Dr. Cooper voiced in 
discussion of his presentation f transcervical thymectomy 
in 1988. 
Regarding comparison of this with a transcervical re- 
sult, seven of the last 10 patients in our series have gone 
home the day after the operation. I think that as we gain 
more comfort with the care of these patients, the mean 
and median hospital stay will continue to become shorter. 
We are also aware of what Dr. Cooper mentioned about 
using the thoracoscope through the cervical incision to aid 
the lower part of the dissection, which is the most difficult 
by that approach. I believe the Toronto group is using that 
now for thymectomY. 
We also are concerned about our low complete remis- 
sion rate. However, five patients who are now 4 to 9 
months postthymectomy appear to be on their way to 
complete remission. We hope that as our follow-up 
lengthens, equivalent complete remission rates will be 
obtained. 
